About: Epidemiological and clinical characteristics of discharged patients infected with SARS‐CoV‐2 on the Qinghai plateau

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Epidemiological and clinical characteristics of discharged patients infected with SARS‐CoV‐2 on the Qinghai plateau Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Epidemiological and clinical characteristics of discharged patients infected with SARS‐CoV‐2 on the Qinghai plateau
Creator	Wang, Xiaoyi Xu, Jian Ma, Xiaoli Bai, Huanying Dai, Jingtao Ding, Yuehe Ma, Xiuzhen Nuermberger, Eric Shi, Lianmeng Xi, Aiqi Zheng, Hongying Zhuo, Ma
Source	Medline; PMC
abstract	Since the outbreak of coronavirus disease 2019 (COVID‐19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) was first reported in Wuhan, a series of confirmed cases of COVID‐19 were found on the Qinghai‐Tibet plateau. We aimed to describe the epidemiological, clinical characteristics, and outcomes of all confirmed cases in Qinghai, a province at high altitude. The region had no sustained local transmission. Of all 18 patients with confirmed SARS‐CoV‐2 infection, 15 patients comprising 4 transmission clusters were identified. Three patients were infected by direct contact without travel history to Wuhan. Of 18 patients, 10 patients showed bilateral pneumonia and 2 patients showed no abnormalities. Three patients with comorbidities such as hypertension, liver diseases or diabetes developed severe illness. High C‐reactive protein levels and elevations of both ALT and AST were observed in 3 severely ill patients on admission. All 18 patients were eventually discharged, including the 3 severe patients who recovered after treatment with non‐invasive mechanical ventilation, convalescent plasma and other therapies. Our findings confirmed human‐to‐human transmission of SARS‐CoV‐2 in clusters. Patients with comorbidities are more likely to develop severe illness. This article is protected by copyright. All rights reserved.
has issue date	2020-05-21(xsd:dateTime)
bibo:doi	10.1002/jmv.26032
bibo:pmid	32437017
has license	no-cc
sha1sum (hex)	8749b10ffcf9629c9196bec5ec4ed411c898d24d
schema:url	https://doi.org/10.1002/jmv.26032
resource representing a document's title	Epidemiological and clinical characteristics of discharged patients infected with SARS‐CoV‐2 on the Qinghai plateau
has PubMed Central identifier	PMC7280617
has PubMed identifier	32437017
schema:publication	J Med Virol
resource representing a document's body	covid:8749b10ffcf9629c9196bec5ec4ed411c898d24d#body_text
is schema:about of	named entity 'transmission' named entity 'cases' named entity 'SARS-CoV-2' named entity 'outbreak' named entity 'identified' named entity 'series' named entity 'infected' named entity 'local transmission' named entity 'severe acute respiratory syndrome coronavirus 2' named entity 'infection' named entity 'Qinghai' named entity 'diabetes' named entity 'ACE2' named entity 'respiratory failure' named entity 'IgG' named entity 'PCR' named entity 'comorbidities' named entity 'neutropenia' named entity 'epidemiological' named entity 'RNA' named entity '3000 meters' named entity 'antibody' named entity 'CT imaging' named entity 'pneumonia' named entity 'SARS-CoV-2' named entity 'ground glass opacities' named entity 'reverse-transcriptase' named entity 'diabetes' named entity 'April 6' named entity 'AST' named entity 'nucleic acid amplification test' named entity 'pneumonia' named entity 'epidemiological' named entity 'Prevention and Control' named entity 'COVID' named entity 'Xi'an, China' named entity 'lung diseases' named entity 'angiotensin-converting enzyme 2' named entity 'clinical characteristics' named entity 'COVID' named entity 'lungs' named entity 'convalescent plasma' named entity 'cough' named entity 'eosinophilia' named entity 'hypertension' named entity 'World Health Organization' named entity 'viral infection' named entity 'traditional Chinese medicine' named entity 'convalescent plasma therapy' named entity 'polymyositis' named entity 'Qinghai province' named entity 'Wuhan' named entity 'Wuhan' named entity 'fatigue' named entity 'COVID' named entity 'demographic data' named entity 'fatigue' named entity 'infection' named entity 'gene' named entity 'Wuhan' named entity 'National Health Commission of the People's Republic of China' named entity 'Hubei Province' named entity 'blood vessels' named entity 'nucleic acid detection' named entity 'antibacterial' named entity 'statistically significant' named entity 'host cells' named entity 'oxygen' named entity 'ethics' named entity 'COVID'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software